Cathepsins B and L are markers for clinically invasive types of meningiomas

Neurosurgery

Volumn 48, Issue 3, 2001, Pages 598-605

  Strojnik, Tadej ^a   Borisidanik, ^a   Kos, Janko ^b,c   Lah, Tamara T ^d  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c Department of Biochemical Research and Drug Design ^*  (Slovenia)

^d NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

Author keywords

Brain tumors; Cathepsins; Diagnostic markers; Invasive meningioma

Indexed keywords

BIOCHEMICAL MARKER; CATHEPSIN B; CATHEPSIN L; CYSTATIN C; STEFIN A;

ADOLESCENT; ADULT; AGED; ANTIBODY LABELING; ARTICLE; BENIGN TUMOR; CLINICAL FEATURE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

ADOLESCENT; ADULT; AGED; CATHEPSIN B; CATHEPSINS; CEREBROSPINAL FLUID PROTEINS; CYSTATINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035093942     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200103000-00029     Document Type: Article

References (0)